Comparative

Human disease

myopia

MONDO:0001384

Mondo defines it as: “The condition in which the individual does not see far distances clearly.”

1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.

Animal diseases

By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.

OMIA group Name Found by Species The chain reached Score
1487 Myopia The group's name 3 Human disease 37.5

Human genes

Each human gene of these disease groups that Open Targets links to this disease.

Open Targets links none of these groups' human genes to this disease.

Drugs tested for this disease

Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.

Drug Acts on Latest stage for this disease
Aflibercept None of these genes Approved
Atropine None of these genes Approved
Vehicle None of these genes Phase 3
7-Methylxanthine None of these genes Phase 2
Tetracaine None of these genes Phase 2
Coda-001 None of these genes Phase 1
Cyclopentolate None of these genes Phase 1
Mitomycin None of these genes Phase 1
Lutein None of these genes Early phase 1
Benoxinate None of these genes Unknown
Dexamethasone None of these genes Unknown
Diquafosol None of these genes Unknown
Ofloxacin None of these genes Unknown
Proparacaine None of these genes Unknown
Tobramycin None of these genes Unknown
Tropicamide None of these genes Unknown

The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.